The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices.

Description

Debris that builds up in the large blood vessels of the leg leads to narrowing of the vessels and reduced blood flow, which can result in leg pain or the development of foot ulcers.

In this procedure, a special cutting device is used inside diseased blood vessels with the aim of removing the excess debris.

Coding recommendations

Percutaneous atherectomy with plaque excision blade catheter for femoro-popliteal arterial lesions:

L71.7 Percutaneous transluminal atherectomy

Y53.- Approach to organ under image control

Z38.- Terminal branch of aorta

Percutaneous atherectomy with plaque excision blade catheter for femoro-popliteal arterial lesions with balloon angioplasty:

L71.7 Percutaneous transluminal atherectomy

L66.5   Percutaneous transluminal balloon angioplasty of artery

Y53.- Approach to organ under image control

Z38.- Terminal branch of aorta

Percutaneous atherectomy with plaque excision blade catheter for femoro-popliteal arterial lesions and insertion of stent:

L71.7 Percutaneous transluminal atherectomy

L63.5 Percutaneous transluminal insertion of stent into femoral artery

L76.- Endovascular placement of stent or L89.- Other endovascular placement of stent

Y53.- Approach to organ under image control

Z38.- Terminal branch of aorta.

Note that it cannot be specifically identified using OPCS-4 codes that a plaque excision blade is used during this procedure. Please note that the .8 and .9 codes from extended category L89 must not be used.

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

  • National Institute for Health and Care Excellence (NICE) accreditation logo